Editorial Advisory Board

Burt Zweigenhaft, BS
Managing Director, BioPharma Partners, LLC
President, National Association of Specialty Pharmacy
Co-Chairman, Association for Value-Based Cancer Care
Chairman, CureVax, LLC
Big Data & Health Information Exchange
Bruce Pyenson, FSA, MAAA
Principal & Healthcare Consultant
Milliman, Inc
New York, NY
Clinical Evidence, Guidelines, & Value
William McGivney, PhD
Managing Partner
McGivney Global Advisors
Philadelphia, PA
Emerging Therapies
Ray Tancredi, RPh, MBA, CSP
Divisional Vice President
Specialty Pharmacy Development
Walgreens Boots Alliance
Deerfield, IL
F. Randy Vogenberg, PhD, RPh, FASHP
Partner, National Institute of Collaborative Healthcare, and Access Market Intelligence
Principal, Institute for Integrated Healthcare
Greenville, SC
Government & Policy
Jayson Slotnik, JD, MPH
Health Policy Strategies, Inc
Bethesda, MD
Hematology & Oncology Community Practice
John D. Sprandio, MD, FACP
Chief Physician, Consultants in Medical Oncology and Hematology
Chairman, Oncology Management Services
Drexel Hill, PA
Patient Advocacy
Robert Goldberg, PhD
President and Co-Founder
Center for Medicine in the Public Interest
Springfield, NJ
Personalized Medicine
Sanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Hospital and Temple University
Philadelphia, PA
Matthew P. Mitchell, PharmD, MBA
Director, Pharmacy Services
Salt Lake City, UT
Specialty Pharmacy
Eric Sredzinski, PharmD, AAHIVP
EVP Clinical and Quality Assurance
Avella Specialty Pharmacy
Phoenix, AZ
Julie K. Silver, MD
Associate Professor and Associate Chair for Strategic Initiatives
Department of Physical Medicine and Rehabilitation
Harvard Medical School
Boston, MA
Al B. Benson III, MD, FACP
Professor of Medicine
Associate Director for Clinical Investigations
Robert H. Lurie Comprehensive
Cancer Center of Northwestern University
Chicago, IL
Past President, ACCC
Past Chair, NCCN Board of Directors
Linda Bosserman, MD, FACP
Clinical Assistant Professor
Medical Oncology and Hematology
City of Hope Medical Group
Rancho Cucamonga, CA
Scott Breidbart, MD
Chief Medical Officer
Empire BlueCross BlueShield
New York, NY

Gena Cook
Co-founder & CEO
Navigating Cancer
Seattle, WA

Bruce Cutter, MD, MMM
Cutter HealthCare Consulting
Spokane, WA
Peter G. Ellis, MD
University of Pittsburgh School of
Medicine and UPMC Cancer Centers
Pittsburgh, PA
Arlene A. Forastiere, MD
Senior Vice President, Medical Affairs
eviti, Inc
Philadelphia, PA
Philip E. Johnson, MS, RPh, FASHP
Pharmacy, Oncology, Healthcare, and School Health Consulting
Tampa, FL

Michael Kolodziej, MD
National Medical Director
Managed Care Strategy
Flatiron Health
New York, NY

Mark J. Krasna, MD
Corporate Medical Director of Oncology
Jersey Shore University Medical Center
Neptune, NJ
Mary Kruczynski
Director of Policy Analysis
Community Oncology Alliance
Washington, DC
Jennifer Malin, MD, PhD
Medical Director
Oncology and Care Management
Anthem, Inc
John L. Marshall, MD
Chief, Hematology and Oncology
Director, Otto J. Ruesch Center for
the Cure of Gastrointestinal Cancers
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Washington, DC
Barbara L. McAneny, MD
Chief Executive Officer
New Mexico Oncology Hematology Consultants, Ltd
Albuquerque, NM
Lee Newcomer, MD
UnitedHealthcare Group
Minnetonka, MN
Lynn Nishida, RPh
Director, Clinical Services
Catamaran Center of Excellence
Northwest Region, Portland, OR
Ted Okon, BS, MBA
Executive Director
Community Oncology Alliance
Washington, DC
Ed Pezalla, MD, MPH
National Medical Director of
Pharmacy Policy and Strategy
Aetna, Hartford, CT
Denise K. Pierce
DK Pierce & Associates
Zionsville, IN
Jatin J. Shah, MD
M.D. Anderson Cancer Center
Houston, TX
Brian K. Solow, MD
Chief Medical Officer
Prescription Solutions/OptumRx
Irvine, CA
G. Rhys Williams, ScD, MS
Thousand Oaks, CA